COO
Price
$62.93Alerts
Change
-$0.64 (-1.01%)
Updated
Nov 11 closing price
Capitalization
11.86B
21 days until earnings call
Intraday BUY SELL Signals
OM
Price
$4.17Alerts
Change
-$0.05 (-1.18%)
Updated
Nov 11 closing price
Capitalization
79.51M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COO vs OM

COO vs OM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COO vs. OM commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a Hold and OM is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COO with price predictions
Nov 11, 2026

COO in downward trend: price may decline as a result of having broken its higher Bollinger Band on November 04, 2026

COO broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 38 similar instances where the stock broke above the upper band. In 23 of the 38 cases the stock fell afterwards. This puts the odds of success at 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for COO moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 14 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 63 cases where COO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on COO as a result. In 47 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.

COO moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COO crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.

Following a +2.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in 152 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

The Aroon Indicator entered an Uptrend today. In 115 of 222 cases where COO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. COO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.424) is normal, around the industry mean (4.964). P/E Ratio (21.283) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.532) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.526) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for OM with price predictions
Nov 11, 2026

OM in upward trend: 10-day moving average moved above 50-day moving average on October 13, 2026

The 10-day moving average for OM crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

OM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +10.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where OM advanced for three days, in 216 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 135 of 157 cases where OM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The 10-day RSI Indicator for OM moved out of overbought territory on October 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 27 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 57 cases where OM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OM as a result. In 80 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for OM turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 34 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

OM broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.825) is normal, around the industry mean (4.142). P/E Ratio (-1.113) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.483) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. OM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
COO vs OM: Fundamental Ratings
COO
OM
OUTLOOK RATING
1..100
7329
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8098
PRICE GROWTH RATING
1..100
4960
P/E GROWTH RATING
1..100
8550
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OM's Valuation (30) in the null industry is in the same range as COO (59) in the Medical Specialties industry. This means that OM’s stock grew similarly to COO’s over the last 12 months.

OM's Profit vs Risk Rating (100) in the null industry is in the same range as COO (100) in the Medical Specialties industry. This means that OM’s stock grew similarly to COO’s over the last 12 months.

COO's SMR Rating (80) in the Medical Specialties industry is in the same range as OM (98) in the null industry. This means that COO’s stock grew similarly to OM’s over the last 12 months.

COO's Price Growth Rating (49) in the Medical Specialties industry is in the same range as OM (60) in the null industry. This means that COO’s stock grew similarly to OM’s over the last 12 months.

OM's P/E Growth Rating (50) in the null industry is somewhat better than the same rating for COO (85) in the Medical Specialties industry. This means that OM’s stock grew somewhat faster than COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOOM
RSI
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
56%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
86%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (COO: $62.93 vs. OM: $4.17)
Brand notoriety: COO and OM are both not notable
COO represents the Pharmaceuticals: Other, while OM is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: COO: 36% vs. OM: 75%
Market capitalization -- COO: $11.86B vs. OM: $79.51M
COO [@Pharmaceuticals: Other] is valued at $11.86B. OM’s [@Medical/Nursing Services] market capitalization is $79.51M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green while OM’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • OM’s FA Score: 1 green, 4 red.
According to our system of comparison, OM is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 5 TA indicator(s) are bullish while OM’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 5 bullish, 4 bearish.
  • OM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, COO is a better buy in the short-term than OM.

Price Growth

COO (@Pharmaceuticals: Other) experienced а -2.31% price change this week, while OM (@Medical/Nursing Services) price change was -6.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.07%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +22.77%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

COO is expected to report earnings on Dec 03, 2026.

OM is expected to report earnings on Feb 17, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+2.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
-1.01%
A - COO
50%
Loosely correlated
-0.52%
BDX - COO
50%
Loosely correlated
+0.90%
ICUI - COO
49%
Loosely correlated
-2.11%
SOLV - COO
47%
Loosely correlated
-1.62%
DHR - COO
46%
Loosely correlated
-0.34%
More

OM and

Correlation & Price change

A.I.dvisor indicates that over the last year, OM has been loosely correlated with COO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OM jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OM
1D Price
Change %
OM100%
-1.18%
COO - OM
34%
Loosely correlated
-1.01%
CVRX - OM
33%
Loosely correlated
+0.70%
RMD - OM
33%
Loosely correlated
+1.89%
GH - OM
32%
Poorly correlated
-0.37%
BDX - OM
31%
Poorly correlated
+0.90%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
HIGH.X0.0220700.000189
+0.86%
Highstreet cryptocurrency
LOKA.X0.123057N/A
N/A
League of Kingdoms Arena cryptocurrency
RAD.X0.222513-0.002342
-1.04%
Radworks cryptocurrency
LUNC.X0.000038-0.000001
-2.19%
Terra Classic cryptocurrency
ID.X0.025435-0.000930
-3.53%
SPACE ID cryptocurrency